Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Clovis Oncology UK Ltd regarding Rucaparib (Rubraca® ): interim data from Study CO-338- 043 (ARIEL4) show a decrease in overall survival compared to standard of care
Important Safety Information – Rucaparib (Rubraca)